Form D/A
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
CITIUS PHARMACEUTICALS, INC.
Jurisdiction of Incorporation/Organization
NEVADA
Year of Incorporation/Organization
Over Five Years Ago
Previous Name(s)
- TRAIL ONE, INC.
- TRAILONE, INC.
Item 2 Issuer Principal Place of Business and Contact Information
11 COMMERCE DRIVE
1ST FLOOR
CRANFORD, NJ 07016
Phone Number:
subscription required
Item 3. Related Persons
Name
MYRON HOLUBIAK
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
LEONARD MAZUR
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
SUREN DUTIA
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
CAROL WEBB
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
WILLIAM KANE
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
HOWARD SAFIR
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
EUGENE HOLUKA
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
Amendment
Date of First Sale in this Offering:
11/23/2016
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Equity
- Option, Warrant or Other Right to Acquire Another Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
50000
Item 13. Offering and Sales Amounts
Total Offering Amount
6000000
Total Amount Sold
549900
Total Remaining to be Sold
5450100
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
9
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
OTHER THAN THE PAYMENT OF SALARIES AND OTHER COMPENSATION AND BENEFITS, NO OFFICER, DIRECTOR, MANAGER OR PROMOTER WILL RECEIVE ANY PAYMENTS FROM THE PROCEEDS OF THIS OFFERING.
Signature and Submission
Issuer Name
CITIUS PHARMACEUTICALS, INC.
Issuer Signature
/S/ MYRON HOLUBIAK
Signer Name
MYRON HOLUBIAK
Signer Title
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Signature Date
02/22/2017